Navigation Links
Inverness Medical Innovations to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009
Date:9/30/2009

WALTHAM, Mass., Sept. 30 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the JMP Securities Healthcare Focus Conference being held on October 5 and 6, 2009 at The New York Palace Hotel. Jon Russell, Vice President, Finance, will attend. Mr. Russell's presentation is scheduled for Tuesday, October 6, 2009 at 10:30 a.m.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

SOURCE Inverness Medical Innovations, Inc.


'/>"/>
SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Inverness Medical Innovations, Inc. Announces Offering of $100 Million of Senior Notes
2. Inverness Medical Innovations Announces September Investor Conference Schedule
3. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
4. Inverness Medical Innovations to Present at the Canaccord Adams Global Growth Conference on August 11, 2009
5. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
6. CVS Caremark and Inverness Medical Innovations Launch Strategic Alliance to Provide Enhanced Health Management Services to Clients
7. Inverness Medical Innovations Announces Second Quarter 2009 Results
8. Inverness Medical Innovations Proposes to Acquire Concateno plc
9. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
10. Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009
11. Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 2016 , ... CarriersEdge, providers of online safety and compliance training tools for ... Offered in three modules, the courses can be used as an extension to an ... how to stay healthy on the road. , “CarriersEdge is now offering a way ...
(Date:12/6/2016)... ... 06, 2016 , ... Of the variety of ingredients in the food supply, ... contrary to common beliefs that hot dogs include “everything but the oink,” today’s wieners ... Ingredients combined with meat and poultry in a hot dog recipe can add flavor, ...
(Date:12/6/2016)... ... December 06, 2016 , ... The NALA, a boutique marketing agency, is ... Foundation (TBCF), a nonprofit 501(C)(3) organization providing financial and emotional support to families ... To assist TBCF, the NALA recently hosted a Thanksgiving food drive that resulted in ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... Autism Center with an Award of Distinction, recognizing the organization as a top ... that excel in the areas of clinical quality, staff satisfaction and qualifications, and ...
(Date:12/6/2016)... Yorba Linda, Ca (PRWEB) , ... December 06, ... ... one of the fastest growing fields in research and development, largely due to ... investigated, including human mesenchymal stem cells (hMSCs) and human induced pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016   Mallinckrodt Pharmaceuticals ... pharmaceutical company, today announced that it received a perfect ... Index (CEI), a national benchmarking survey and report on ... and transgender (LGBT) workplace equality, administered by the Human ... 517 major U.S. businesses which also earned top marks ...
(Date:12/5/2016)... 5, 2016  Cornerstone Pharmaceuticals, Inc., a privately ... from two Phase I trials evaluating its lead ... annual meeting of the American Society of Hematology ... . The two datasets show encouraging efficacy and ... (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), respectively, ...
(Date:12/5/2016)... BOULDER, Colo. , Nov. 29, 2016 ... webinar hosted by Accera, Inc. at 11 ... 9th Annual International Conference on Clinical Trials for Alzheimer,s ... role of metabolism in Alzheimer,s disease and therapeutic targets ... patients. "Following the recent failure of another ...
Breaking Medicine Technology: